Halozyme Therapeutics Net Non-Operating Interest Income Expense (Quarterly) Trends

Halozyme Therapeutics, Inc. (HALO)

67.30 -0.40 (-0.60%) USD | NASDAQ | Dec 31, 16:00

67.17 -0.12 (-0.19%) After-Hours: 17:08

View Net Non-Operating Interest Income Expense (Quarterly) for HALO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Johnson & Johnson	Upgrade
Merck & Co., Inc.	Upgrade
AIM ImmunoTech, Inc.	Upgrade
Bristol Myers Squibb Co.	Upgrade
Protalix Biotherapeutics, Inc.	Upgrade